Additional US Equity stories post the release of the US Equity Opening News
SourceNewsquawk
SectionUS Equities
NASDAQ 100
Bio-Marin (BMRN) – The co. announces it has entered into a definitive agreement to sell the Rate Paediatric Disease Priority Review Voucher it obtained in April for USD 125mln. (Newswires)
Other News
Barracuda (CUDA) – The co. has agreed to be acquired by Thoma Bravo for USD 27.55/shr valued at USD 1.6bln. (Newswires)
Teva Pharmaceuticals (TEVA) – The co. is no longer going to have two separate global groups for generics and specialty medicines. (Newswires)
Free. No signup, no card.
Use the Platform